1. Repository of OAI
Ελληνικά   English  

Browsing by Author Kostapanos, M. S.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 4 to 23 of 34 < previous   next >
TitleAuthor(s)Issue date???itemlist.???
Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in patients with primary hyperlipidemiaKostapanos, M. S.; Milionis, H. J.; Lagos, K. G.; Rizos, C. B.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Clopidogrel vs. aspirin treatment on admission improves 5-year survival after a first-ever acute ischemic stroke. data from the Athens Stroke Outcome ProjectMilionis, H. J.; Gerotziafas, G.; Kostapanos, M. S.; Vemmou, A.; Zis, P.; Spengos, K.; Elisaf, M. S.; Vemmos, K. N.24-Nov-2015-
Comparison of the effects of simvastatin vs. rosuvastatin vs. simvastatin/ezetimibe on parameters of insulin resistanceMoutzouri, E.; Liberopoulos, E.; Mikhailidis, D. P.; Kostapanos, M. S.; Kei, A. A.; Milionis, H.; Elisaf, M. S.24-Nov-2015-
Current role of statins in the treatment of essential hypertensionKostapanos, M. S.; Milionis, H. J.; Elisaf, M. S.24-Nov-2015-
Different definitions of the metabolic syndrome and risk of first-ever acute ischaemic non-embolic stroke in elderly subjectsMilionis, H. J.; Kostapanos, M. S.; Liberopoulos, E. N.; Goudevenos, J.; Athyros, V. G.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Distinct effects of fixed combinations of valsartan with either amlodipine or hydrochlorothiazide on lipoprotein subfraction profile in patients with hypertensionChristogiannis, L. G.; Kostapanos, M. S.; Tellis, C. C.; Milionis, H. J.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Do statins beneficially or adversely affect glucose homeostasis?Kostapanos, M. S.; Liamis, G. L.; Milionis, H. J.; Elisaf, M. S.24-Nov-2015-
Do statins have an antiarrhythmic activity?Kostapanos, M. S.; Liberopoulos, E. N.; Goudevenos, J. A.; Mikhailidis, D. P.; Elisaf, M. S.24-Nov-2015-
Dose-dependent Effect of Rosuvastatin Treatment on HDL-subfraction Phenotype in Patients With Primary HyperlipidemiaKostapanos, M. S.; Milionis, H. J.; Filippatos, T. D.; Christogiannis, L. G.; Bairaktari, E. T.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Dose-dependent effect of rosuvastatin treatment on urinary protein excretionKostapanos, M. S.; Milionis, H. J.; Saougos, V. G.; Lagos, K. G.; Kostara, C.; Bairaktari, E. T.; Elisaf, M. S.24-Nov-2015-
Editorial: reducing cardiovascular risk: is low-density lipoprotein-cholesterol (LDL-C) lowering enough?Kostapanos, M. S.; Katsiki, N.; Elisaf, M. S.; Mikhailidis, D. P.24-Nov-2015-
Effect of Ezetimibe on Markers of Oxidative Stress in Patients with HypercholesterolemiaKostapanos, M. S.; Spyrou, A. T.; Tellis, C. C.; Gazi, I. F.; Tselepis, A. D.; Liberopoulos, E. N.; Elisaf, M. S.24-Nov-2015-
Effect of rosuvastatin treatment on plasma visfatin levels in patients with primary hyperlipidemiaKostapanos, M. S.; Derdemezis, C. S.; Filippatos, T. D.; Milionis, H. J.; Kiortsis, D. N.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
EFFECT OF STANDARD COMBINATION OF VALSARTAN WITH EITHER AMLODIPINE OR HYDROCHLOROTHIAZIDE ON LDL SUBFRACTION PROFILE IN PATIENTS WITH HYPERTENSIONChristogiannis, L. G.; Kostapanos, M. S.; Milionis, H. J.; Mitrogianni, Z.; Moutzouri, E.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Effects of Orlistat and Fenofibrate, Alone or in Combination, on Plasma Apolipoprotein C-Ii and C-Iii Levels in Metabolic Syndrome PatientsFilippatos, T. D.; Kostapanos, M. S.; Kostara, C.; Nakou, E. S.; Georgoula, M.; Derdemezis, C. S.; Kiortsis, D. N.; Bairaktari, E. T.; Tselepis, A. D.; Elisaf, M. S.24-Nov-2015-
Effects of rosuvastatin combined with olmesartan, irbesartan, or telmisartan on indices of glucose metabolism in Greek adults with impaired fasting glucose, hypertension, and mixed hyperlipidemia: a 24-week, randomized, open-label, prospective studyRizos, C. V.; Milionis, H. J.; Kostapanos, M. S.; Florentin, M.; Kostara, C. E.; Elisaf, M. S.; Liberopoulos, E. N.24-Nov-2015-
Efficacy and safety of ezetimibe plus orlistat or rimonabant in statin-intolerant nondiabetic overweight/obese patients with dyslipidemiaFlorentin, M.; Kostapanos, M. S.; Nakou, E. S.; Elisaf, M. S.; Liberopoulos, E. N.24-Nov-2015-
Ezetimibe Treatment Lowers Indicators of Oxidative Stress in Hypercholesterolemic Subjects with High Oxidative StressKostapanos, M. S.; Spyrou, A. T.; Tellis, C. C.; Gazi, I. F.; Tselepis, A. D.; Elisaf, M.; Liberopoulos, E. N.24-Nov-2015-
High-Density Lipoprotein Subclasses in Patients with or without the Metabolic SyndromeLagos, K. G.; Gazi, I. F.; Kostapanos, M. S.; Filippatos, T.; Kazakou, P. S.; Rizos, C. V.; Tselepis, A. D.; Elisaf, M.24-Nov-2015-
Hypertriglyceridaemic waist phenotype criteria and prevalent metabolic triad in womenGazi, I. F.; Milionis, H. J.; Filippatos, T. D.; Tsimihodimos, V.; Kostapanos, M. S.; Doumas, M.; Tselepis, A. D.; Elisaf, M.24-Nov-2015-
Showing results 4 to 23 of 34 < previous   next >